Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bilibili Inc BILI

Bilibili Inc is a China-based company principally engaged in the Internet and other related businesses. The Company operates its business through four segments. The Mobile Games segment mainly publishes mobile games on its platform for third-party game developers which are free to download and play with Bilibili accounts. The Advertising segment is mainly engaged in display advertising arrangements business. The Live broadcasting and Value-added services (VAS) segment mainly generates revenue from subscription fee of premium membership program, sales of in-channel virtual items and sales of paid content and virtual items on its video, audio and comic platforms. The E-commerce and Others segment mainly engages in the online sales of anime, comics and games (AGG)-related merchandise and offline performance events and activities.


NDAQ:BILI - Post by User

<< Previous
Bullboard Posts
Next >>
Post by MitchelleTon Jun 03, 2022 5:08am
99 Views
Post# 34728745

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance



FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


 
<< Previous
Bullboard Posts
Next >>